Warm Wishes for Lohri

delveinsight-discount

The only word that described 2016’s pharma M&A market was “slow.” Some do predict that new year—and administration—could revive energy in the deal making arena, the changes might not happen that fast. The reasons are aplenty, as shares have been sagging under the weight of investor fears of drug-pricing reform. ...

US drug approvals are on track to drop by more than half in 2016 compared to 2015. The agency had approved 19 new drugs this year as of 9 December, putting it on track for its lowest yearly tally since 2007. The decline is made more dramatic by 2015’s bumper crop of approvals. The FDA approved 45 new drugs last year...

Anterior uveitis is a set of conditions defined by intraocular inflammation and is believed to be the cause of up to 10% of legal blindness in the United States, or approximately 30,000 new cases of blindness per year. Anterior uveitis is an intraocular inflammation of the uveal structures. The uvea is situated ante...

Fabián Díaz achieved a milestone last year when he derived the first human embryonic stem-cell line from cells of Mexican origin. Biologists across Mexico now use the stem cells, which Díaz — a researcher at the National Institute of Perinatology in Mexico City — created using embryos discarded by a fertility clinic...